GeneBio Systems
FLT3 Polyclonal Antibody
FLT3 Polyclonal Antibody
SKU:E-AB-10844
Couldn't load pickup availability
Size::120μL
Storage:Store at -20℃ Valid for 12 months. Avoid freeze / thaw cycles.
Shipping:The product is shipped with ice pack,upon receipt,store it immediately at the temperature recommended.
Exp date:12 months
Category ID_II:Primary Antibodies
Category ID_III:Polyclonal Antibodies
Abbreviation:FLT3
Target Synonym:CD 135;CD135;CD135 antigen;Fetal liver kinase 2;FL cytokine receptor;Flk 2;Flk2;Flt 3;FLT-3;Flt3;FLT3;FMS like tyrosine kinase 3;Fms related tyrosine kinase 3;Fms-like tyrosine kinase 3;Growth factor receptor tyrosine kinase type III;Ly-72;OTTHUMP0000004234;Receptor type tyrosine protein kinase FLT3;Stem cell tyrosine kinase 1;Stk 1;STK-1;Stk1;Tyrosine protein kinase receptor FLT3;Tyrosine-protein kinase receptor FLT3
Research Areas:Immunology;Signal Transduction
Conjugation:Unconjugated
Host:Rabbit
Species reactivity:Human;Mouse
Application:IHC
Isotype:IgG
Clonality:Polyclonal
Clone NO.:
UNIProt ID:P36888
Accession:
Background:This gene encodes a class III receptor tyrosine kinase that regulates hematopoiesis. The receptor consists of an extracellular domain composed of five immunoglobulin-like domains, one transmembrane region, and a cytoplasmic kinase domain split into two parts by a kinase-insert domain. The receptor is activated by binding of the fms-related tyrosine kinase 3 ligand to the extracellular domain, which induces homodimer formation in the plasma membrane leading to autophosphorylation of the receptor. The activated receptor kinase subsequently phosphorylates and activates multiple cytoplasmic effector molecules in pathways involved in apoptosis, proliferation, and differentiation of hematopoietic cells in bone marrow. Mutations that result in the constitutive activation of this receptor result in acute myeloid leukemia and acute lymphoblastic leukemia.
Concentration:0.5 mg/mL
Immunogen:Recombinant protein of human FLT3
Buffer:PBS with 0.05% sodium azide and 50% glycerol, PH7.4
Purification method:Affinity purification
Dilution:IHC 1:50-1:200
Calculated MW:
ObservedMW:
